BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18652661)

  • 1. New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.
    Cepa M; Correia-da-Silva G; da Silva EJ; Roleira FM; Borges M; Teixeira NA
    BMC Cell Biol; 2008 Jul; 9():41. PubMed ID: 18652661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy.
    Amaral C; Varela C; Azevedo M; da Silva ET; Roleira FM; Chen S; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2013 May; 135():51-9. PubMed ID: 23318878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells.
    Amaral C; Varela CL; Maurício J; Sobral AF; Costa SC; Roleira FMF; Tavares-da-Silva EJ; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2017 Jul; 171():218-228. PubMed ID: 28396197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
    Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
    J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroidal aromatase inhibitors inhibit growth of hormone-dependent breast cancer cells by inducing cell cycle arrest and apoptosis.
    Amaral C; Varela C; Borges M; Tavares da Silva E; Roleira FMF; Correia-da-Silva G; Teixeira N
    Apoptosis; 2013 Nov; 18(11):1426-1436. PubMed ID: 23842740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
    Kijima I; Itoh T; Chen S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential biological effects of aromatase inhibitors: Apoptosis, autophagy, senescence and modulation of the hormonal status in breast cancer cells.
    Augusto TV; Amaral C; Almeida CF; Teixeira N; Correia-da-Silva G
    Mol Cell Endocrinol; 2021 Nov; 537():111426. PubMed ID: 34391846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of aromatase inhibition by new A, D-ring modified steroids.
    Cepa M; Correia-da-Silva G; Tavares da Silva EJ; Roleira FM; Hong Y; Chen S; Teixeira NA
    Biol Chem; 2008 Sep; 389(9):1183-91. PubMed ID: 18713005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor.
    Masri S; Phung S; Wang X; Wu X; Yuan YC; Wagman L; Chen S
    Cancer Res; 2008 Jun; 68(12):4910-8. PubMed ID: 18559539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone-dependent breast cancer: Targeting autophagy and PI3K overcomes Exemestane-acquired resistance.
    Amaral C; Augusto TV; Tavares-da-Silva E; Roleira FMF; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2018 Oct; 183():51-61. PubMed ID: 29791862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.
    Lisztwan J; Pornon A; Chen B; Chen S; Evans DB
    Breast Cancer Res; 2008; 10(4):R56. PubMed ID: 18611244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis and autophagy in breast cancer cells following exemestane treatment.
    Amaral C; Borges M; Melo S; da Silva ET; Correia-da-Silva G; Teixeira N
    PLoS One; 2012; 7(8):e42398. PubMed ID: 22912703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring new chemical functionalities to improve aromatase inhibition of steroids.
    Varela CL; Amaral C; Correia-da-Silva G; Costa SC; Carvalho RA; Costa G; Alcaro S; Teixeira NA; Tavares-da-Silva EJ; Roleira FM
    Bioorg Med Chem; 2016 Jun; 24(12):2823-31. PubMed ID: 27160054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beneficial androgenic action of steroidal aromatase inactivators in estrogen-dependent breast cancer after failure of nonsteroidal drugs.
    Gao L; Bao Z; Deng H; Li X; Li J; Rong Z; Yang Y; Liu L; Nie D; Wang G; Teichmann AT; Wieland FH
    Cell Death Dis; 2019 Jun; 10(7):494. PubMed ID: 31235695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitors and their antitumor effects in model systems.
    Brodie A; Lu Q; Liu Y; Long B
    Endocr Relat Cancer; 1999 Jun; 6(2):205-10. PubMed ID: 10731110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER
    Amaral C; Correia-da-Silva G; Almeida CF; Valente MJ; Varela C; Tavares-da-Silva E; Vinggaard AM; Teixeira N; Roleira FMF
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 inhibitor nimesulide analogs are aromatase suppressors in breast cancer cells.
    Su B; Cai X; Hong Y; Chen S
    J Steroid Biochem Mol Biol; 2010 Oct; 122(4):232-8. PubMed ID: 20542113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications.
    Hanamura T; Hayashi SI
    Breast Cancer; 2018 Jul; 25(4):379-391. PubMed ID: 28389808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells.
    Amanatullah DF; Tamaresis JS; Chu P; Bachmann MH; Hoang NM; Collyar D; Mayer AT; West RB; Maloney WJ; Contag CH; King BL
    Breast Cancer Res; 2017 Nov; 19(1):121. PubMed ID: 29141657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?
    Howell A; Howell SJ; Clarke R; Anderson E
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):227-37. PubMed ID: 11850229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.